pharmacokinetics
43 projects
H2020Doctoral network2017–2021Germany
transMed · Educating the next generation of scientists in translational medicine: Focus on eye diseases
14 partners · 7 countries
H2020Staff exchange2017–2022Finland
VAHVISTUS · Integrative development of smart drug-vector nanostructures for adaptive delivery to target cells
8 partners · 6 countries
H2020Doctoral network2016–2020Finland
OcuTher · Educational Network in Ocular Drug Delivery and Therapeutics
18 partners · 9 countries
H2020Individual fellowship2016–2018Ireland
CF_struct · High-Resolution X-ray Structures of Full-Length Cystic Fibrosis Transmembrane Conductance Regulator
H2020Staff exchange2016–2019Serbia
MEDLEM · Cost-effective microfluidic electronic devices for optimal drug administration based on fractional pharmacokinetics for leukemia treatments
6 partners · 5 countries
H2020Individual fellowship2016–2018Spain
CHELALZ · Multitarget compounds with therapeutic potential against Alzheimer disease: Design and in vitro studies
H2020Individual fellowship2015–2017Austria
DrugsUP · Solute carrier proteins and the uptake of cytotoxic approved drugs
H2020Individual fellowship2015–2018Germany
INSCAPE · Imaging Voltage Gated Sodium Channels Using Positron Emission Tomography
2 partners · 2 countries
H2020Doctoral network2015–2019Italy
NABBA · Design and development of advanced NAnomedicines to overcome Biological BArriers and to treat severe diseases
10 partners · 7 countries
FP7Reintegration grant2012–2016Sweden
DARMEC · Drug adverse reactions predictability: exploring the mechanisms underlying the unexplained interindividual differences in drug metabolism and transport
FP7Individual fellowship2012–2014Spain
NanoBioMOFs · Nanoscale Metal–Organic Frameworks for Biomedical Applications
FP7Reintegration grant2011–2015Israel
TARGETIBDBYPLA2 · A Novel Drug Targeting Strategy for the Treatment of Inflammatory Bowel Disease: A Molecular Biopharmaceutical Approach
FP7Individual fellowship2009–2011Netherlands
SAHNMAT · Self-assembly of Helical Functional Nanomaterials
FP7Reintegration grant2008–2012Greece
IN VITRO PKPD SYSTEM · In vitro pharmacokinetic/pharmacodynamic system for antifungal combination therapy against filamentous fungi
FP6Individual fellowship2006–2010United Kingdom
MEDCHEM AT QUB/GSK · New methodologies to synthetise unnatural nucleosides, known and putative antiproliferative agents
FP6Individual fellowship2005–2007Sweden
TRAINGERTJE · Modelling multimedia fate and exposure of organic chemicals
FP6Individual fellowship2005–2007Sweden
TRAINGERTJE · Modelling multimedia fate and exposure of organic chemicals
FP6Reintegration grant2005–2006Spain
CYP3A4 VARIBILITY · Identification and characterization of the factors involved in CYP3A4 inter-individual variability
FP5Training site2003–2007Netherlands